C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/22/2004	EP1487997A2 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
12/22/2004	EP1487995A2 Protein carrier system for therapeutic oligonucleotides
12/22/2004	EP1487994A2 Methods for creating recombination products between nucleotide sequences
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487991A2 Cancer-linked gene as target for chemotherapy
12/22/2004	EP1487989A2 Molecules for disease detection and treatment
12/22/2004	EP1487987A2 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
12/22/2004	EP1487986A2 METHOD OF PREPARING A TREATMENT PRODUCT, TREATMENT PRODUCT AND A PLASMID CONSTRUCT
12/22/2004	EP1487985A2 Transgenic plants expressing enzymes involved in fatty acid biosynthesis
12/22/2004	EP1487984A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
12/22/2004	EP1487983A2 Prevention of recurrence and metastasis of cancer
12/22/2004	EP1487982A1 CONSTRUCTION OF NOVEL STRAINS CONTAINING MINIMIZING GENOME BY Tn5-COUPLED Cre/loxp EXCISION SYSTEM
12/22/2004	EP1487981A2 Growth regulating proteins
12/22/2004	EP1487980A1 Modified gene-silencing rna and uses thereof
12/22/2004	EP1487979A1 Constructs and methods for the regulation of gene expression
12/22/2004	EP1487978A2 An improved method for synthesising templated molecules
12/22/2004	EP1487977A1 Method to isolate dna
12/22/2004	EP1487976A2 Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
12/22/2004	EP1487975A2 Serine hydroxymethyltransferase as a target for herbicides
12/22/2004	EP1487973A1 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
12/22/2004	EP1487972A2 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use
12/22/2004	EP1487971A2 MEANS AND METHODS FOR MANIPULATING HYPERSENSITIVITY−LIKE RESPONSES
12/22/2004	EP1487968A1 Methods of inducing differentiation of stem cells into a specific cell lineage
12/22/2004	EP1487966A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
12/22/2004	EP1487965A2 Minicell compositions and methods
12/22/2004	EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor
12/22/2004	EP1487875A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
12/22/2004	EP1487873A1 P-rex1, a ptdins(3,4,5)p3- g-beta-gamma-regulated guanine-nucleotide exchange factor for rac
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487868A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
12/22/2004	EP1487864A2 Therapeutic polypeptides nucleic acids encoding same, and methods of use
12/22/2004	EP1487858A2 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
12/22/2004	EP1487857A1 Lymphatic and blood endothelial cell genes
12/22/2004	EP1487856A2 Human antibodies specific to kdr and uses thereof
12/22/2004	EP1487855A2 Method of using modified oligonucleotides for hepatic delivery
12/22/2004	EP1487854A2 Novel isoforms of vascular endothelial ell growth inhibitor
12/22/2004	EP1487853A2 Secretion, transcription and sporulation genes in bacillus clausii
12/22/2004	EP1487851A2 A building block capable of functional entity transfer to nucleophil
12/22/2004	EP1487850A2 A building block forming a c-c or a c-hetero atom bond upon reaction
12/22/2004	EP1487849A2 A building block capable of transferring a functional entity
12/22/2004	EP1487848A2 A building block forming a c=c double bond upon reaction
12/22/2004	EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
12/22/2004	EP1487565A1 Process for preparing processed sample liquid solution for electrophoresis
12/22/2004	EP1487501A2 A phosphatase associated with metastasis
12/22/2004	EP1487499A2 Contrast agents for magnetic resonance imaging and methods related thereto
12/22/2004	EP1487490A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
12/22/2004	EP1487486A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
12/22/2004	EP1487483A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/22/2004	EP1487482A2 Dna vaccine against proliferating endothelial cells and methods of use thereof.
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487478A2 Interferon beta-like molecules for treatment of stroke
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487463A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors
12/22/2004	EP1487412A1 Chemosensitizing with liposomes containing oligonucleotides
12/22/2004	EP1487280A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
12/22/2004	EP1487269A1 Autoinducer compounds
12/22/2004	EP1487261A2 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/22/2004	EP1487260A2 The functional disruption of avian immunoglobulin genes
12/22/2004	EP1444339A4 Novel method for transgenic plants by transformation & regeneration of indica rice plant shoot tips
12/22/2004	EP1381682A4 Modulators of leukocyte activation, compositions and methods of use
12/22/2004	EP1363961A4 End group activated polymers with oligonucleotide ligands
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1272629A4 Genetic silencing
12/22/2004	EP1255866A4 Microarray methods utilizing semiconductor nanocrystals
12/22/2004	EP1222306B1 Cellulose films for screening
12/22/2004	EP1220953B1 Template-dependent ligation with pna-dna chimeric probes
12/22/2004	EP1196425A4 Detection of giardia
12/22/2004	EP1196027A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1192720A4 Anchored strand displacement amplification on an electronically addressable microchip
12/22/2004	EP1177311A4 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
12/22/2004	EP1175430A4 Antisense-oligos with better stability and antisense effect
12/22/2004	EP1154990B1 Phthalamide-lanthanide complexes for use as luminescent markers
12/22/2004	EP1114148A4 System for the rapid manipulation of nucleic acid sequences
12/22/2004	EP1054959A4 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
12/22/2004	EP0966531B1 Tazarotene-induced gene 3 (tig3)
12/22/2004	EP0906110B1 Dna vaccine formulations
12/22/2004	EP0832271B1 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
12/22/2004	EP0832253B9 Nucleic acid respiratory syncytial virus vaccines
12/22/2004	EP0815236B1 Haemophilus adhesion proteins
12/22/2004	EP0786005B1 Compositions for treatment of coronary artery diseases using gene therapy.
12/22/2004	EP0749441B1 Expression and purification of cloned human alpha-fetoprotein
12/22/2004	EP0677110B1 Recombinant lactic acid bacterium containing an inserted promoter
12/22/2004	EP0658200B1 Glucagon receptors
12/22/2004	CN1556863A Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
12/22/2004	CN1556862A Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
12/22/2004	CN1556861A Nucleid acid sequencing by Raman monitoring of molecular deconstruction
12/22/2004	CN1556858A Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
12/22/2004	CN1556857A Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
12/22/2004	CN1556856A Vaccines from infectious agents
12/22/2004	CN1556855A 3-hydroxypropionic acid and other organic compounds
12/22/2004	CN1556850A Product and process for transformation of thraustochytriales microorganisms
12/22/2004	CN1556816A Application of cardiokinetic hormone in liver disease
12/22/2004	CN1556815A Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease
12/22/2004	CN1556814A Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunit
12/22/2004	CN1556211A Universal carrier used for transgenic kelp and its application in ruitipu enzyme expression
12/22/2004	CN1556210A Human protein phosphokinase 2A point mutanted lung cancer related antigen gene
12/22/2004	CN1556209A Anti longicorn Bt gene and its application
12/22/2004	CN1556208A Method of preparing polypeptide segment capable of indeperdent expression
12/22/2004	CN1556114A Human dry cell factor macrophage clong irritant factor bifunction protein and its preparation

1 ... 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 ... 4023